Sound alarms are blaring over an escalating partnership between Russia and China to subvert the U.S. military amid rising hostility…
Moderna stock surged after its personalized mRNA cancer vaccine produced positive late-stage trial results with Merck’s Keytruda. Marvell Technology shares…